Qiagen NV | QIA - Ebitda

Stock Price
43.73
Daily Change
-0.31 -0.69%
Monthly
12.50%
Yearly
4.38%
Q1 Forecast
43.53

Qiagen NV reported $193.17M in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
Alaunos Therapeutics USD -21.02M 1.33M Mar/2021
argenx SE USD 288.02M 84.53M Jun/2025
Avita Medical AUD -21.9M 12.04M Jun/2025
Dianthus Therapeutics USD -40.19M 5.36M Sep/2025
Ionis Pharmaceuticals USD -157.12M 307.36M Sep/2025
IQVIA Holdings USD 949M 39M Sep/2025
Moderna USD -208M 552M Sep/2025
Organon & Co USD 518M 4M Sep/2025
Qiagen NV USD 193.17M 15.81M Sep/2025
Revvity USD 248.91M 48.52M Dec/2025
Tectonic Therapeutic USD -13.48M 5.73M Dec/2024
Viatris USD 1.15B 75.8M Sep/2025
Xeris Pharmaceuticals USD 17.42M 8.83M Sep/2025